Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Frendl

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Medical Care|June 14, 2014
Clinical and policy perspectives on the adoption of active surveillance for low-risk prostate cancerDaniel M Frendl, Mitchell H Sokoloff
Cancer|May 26, 2017
Understanding temporal trends in medical costs associated with progression to metastatic prostate cancerDaniel M Frendl, Aria F Olumi
Urology Practice|August 19, 2023
Editorial CommentaryDaniel M Frendl, Mitchell H Sokoloff
The Journal of Urology|June 9, 2023
Editorial CommentDerek J Lomas, Daniel M Frendl
Medical Care|April 10, 2014
Patient-reported functional health and well-being outcomes with drug therapy: a systematic review of randomized trials using the SF-36 health surveyDaniel M Frendl, John E Ware
Urology Practice|October 23, 2025
Editorial CommentaryDaniel M Frendl, Ram A Pathak, Derek J Lomas
The Journal of Urology|May 22, 2020
Reply by AuthorsHu Zhang, Daniel M Frendl, Zongwei Wang, et al.
The Journal of Urology|March 14, 2020
High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic HyperplasiaHu Zhang, Daniel M Frendl, Zongwei Wang, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|July 23, 2014
Assessing health-related quality of life in patients with benign non-toxic goitreTorquil Watt, Per Cramon, Daniel M Frendl, et al.
The Journal of Urology|October 7, 2020
A Claims Based Assessment of Reoperation and Acute Urinary Retention after Ambulatory Transurethral Surgery for Benign Prostatic HyperplasiaDaniel M Frendl, Ya-Wen Chen, David C Chang, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Medical Care|June 14, 2014
Clinical and policy perspectives on the adoption of active surveillance for low-risk prostate cancerDaniel M Frendl, Mitchell H Sokoloff
Cancer|May 26, 2017
Understanding temporal trends in medical costs associated with progression to metastatic prostate cancerDaniel M Frendl, Aria F Olumi
Urology Practice|August 19, 2023
Editorial CommentaryDaniel M Frendl, Mitchell H Sokoloff
The Journal of Urology|June 9, 2023
Editorial CommentDerek J Lomas, Daniel M Frendl
Medical Care|April 10, 2014
Patient-reported functional health and well-being outcomes with drug therapy: a systematic review of randomized trials using the SF-36 health surveyDaniel M Frendl, John E Ware
Urology Practice|October 23, 2025
Editorial CommentaryDaniel M Frendl, Ram A Pathak, Derek J Lomas
The Journal of Urology|May 22, 2020
Reply by AuthorsHu Zhang, Daniel M Frendl, Zongwei Wang, et al.
The Journal of Urology|March 14, 2020
High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic HyperplasiaHu Zhang, Daniel M Frendl, Zongwei Wang, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|July 23, 2014
Assessing health-related quality of life in patients with benign non-toxic goitreTorquil Watt, Per Cramon, Daniel M Frendl, et al.
The Journal of Urology|October 7, 2020
A Claims Based Assessment of Reoperation and Acute Urinary Retention after Ambulatory Transurethral Surgery for Benign Prostatic HyperplasiaDaniel M Frendl, Ya-Wen Chen, David C Chang, et al.
Pageof 2